Review and meta-analysis of usage of ginkgo as an adjunct therapy in chronic schizophrenia.

@article{Singh2010ReviewAM,
  title={Review and meta-analysis of usage of ginkgo as an adjunct therapy in chronic schizophrenia.},
  author={Vidhi Singh and Surendra P. Singh and Kelvin Chan},
  journal={The international journal of neuropsychopharmacology},
  year={2010},
  volume={13 2},
  pages={
          257-71
        }
}
This study aimed to review the roles of antioxidants in the pathophysiology of schizophrenia, whether the properties of ginkgo can ameliorate symptoms of this illness, and evaluate available literature to test this assumption. This review is based upon published works on antioxidants and ginkgo. A primary electronic search for meta-analysis on the usage of ginkgo or its derived products in schizophrenia was conducted using Pubmed, Cochrane Library, EMBASE, CINAHL, PsycINFO and AMED. Inclusion… Expand
Meta-Analysis of the Efficacy of Adjunctive NMDA Receptor Modulators in Chronic Schizophrenia
TLDR
Taking into consideration the number of trials and sample size in subgroup analyses, D-serine, NAC and sarcosine as adjuncts to non-clozapine antipsychotics have therapeutic benefit in the treatment of negative and total symptoms of chronic schizophrenia. Expand
Effectiveness of Traditional Chinese Medicineas as an Adjunct Therapy for Refractory Schizophrenia: A Systematic Review and Meta Analysis
TLDR
The results indicated the potential utility of TCM as an alternative adjunctive therapeutic for refractory schizophrenia treatment, but there remains a need for further high-quality studies. Expand
Efficacy and safety of extract of Ginkgo biloba as an adjunct therapy in chronic schizophrenia: A systematic review of randomized, double-blind, placebo-controlled studies with meta-analysis
TLDR
The result showed that EGb had a significant difference in ameliorating total and negative symptoms of chronic schizophrenia as an adjuvant therapy to antipsychotics and the EGb therapy plus antipsychotic might be more efficacious. Expand
Traditional Chinese Medicine Decoction Combined With Antipsychotic for Chronic Schizophrenia Treatment: A Systematic Review and Meta-analysis
TLDR
It was found that adjuvant treatment with TCM can reduce some side effects and improve the patient's living conditions in the evaluation of the Schizophrenia Quality Of Life Scale (SQLS). Expand
Antioxidant therapeutics for schizophrenia.
TLDR
The totality of the evidence to date suggests that specific antioxidants, such as N-acetyl cysteine, may offer tangible benefits for the clinical syndrome of schizophrenia, and vitamin E may offer salutary effects on glycemic effects of antipsychotics. Expand
The Role of Herbal and Nutraceutical Supplementation in the Amelioration of Schizophrenia and Schizoaffective Symptomology
TLDR
The purpose of this overview is to present the latest empirical findings regarding the efficacy of various herbal and nutraceutical supplements in the prevention, treatment, and delaying onset of symptomology in relation to schizophrenia and other schizoaffective disorders. Expand
Effect of herbal and nutritional products on the central nervous system effects of haloperidol: a systematic review
Haloperidol is widely used in treatments of acute and chronic schizophrenia. Due to the narrow therapeutic window of haloperidol and the increasing popularity of herbal and nutritional productsExpand
Natural Medicines for Psychotic Disorders
TLDR
In 110 randomized controlled trials, evidence was found for glycine, sarcosine, N-acetylcysteine, some Chinese and ayurvedic herbs, ginkgo biloba, estradiol, and vitamin B6 to improve psychotic symptoms when added to antipsychotics. Expand
Emerging drugs for schizophrenia
TLDR
Although clinicians will have to have considerable patience before truly novel anti-schizophrenia treatments become obtainable, a number of interesting leads with considerable theoretical potential are being explored. Expand
Oxidative Stress in Schizophrenia
TLDR
There is a need for well designed, placebo controlled trials with supplementation therapy in schizophrenia, according to the meta-analysis vitamin E could potentially improve tardive dyskinesia, while for the effect of therapy with polyunsaturated fatty acids there is no clear evidence. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 114 REFERENCES
A placebo-controlled study of extract of ginkgo biloba added to clozapine in patients with treatment-resistant schizophrenia
TLDR
Preliminary data suggested that EGb was found useful for enhancing the effect of clozapine on negative symptoms in patients with treatment-resistant schizophrenia. Expand
[Evidence for a therapeutic effect of Ginkgo biloba special extract. Meta-analysis of 11 clinical studies in patients with cerebrovascular insufficiency in old age].
TLDR
The analysis of the total score of clinical symptoms from all relevant studies indicated that 7 studies confirmed the effectiveness (Ginkgo biloba being better compared to placebo) while only one study was inconclusive (the medications were not different), which confirms the therapeutical effectiveness of gink go biloba regarding the clinical symptom complex. Expand
The Effect of Extract of Ginkgo Biloba Added to Haloperidol on Superoxide Dismutase in Inpatients With Chronic Schizophrenia
TLDR
EGb may enhance the efficiency of the classic antipsychotic haloperidol in patients with schizophrenia, especially on their positive symptoms, and that EGb may work through an antioxidant effect that is involved in the therapeutic mechanism in Patients with chronic refractory schizophrenia. Expand
Extract of Ginkgo biloba added to haloperidol was effective for positive symptoms in refractory schizophrenia
  • M. Knable
  • Medicine
  • Evidence-based mental health
  • 2002
TLDR
A double-blind, placebo-controlled trial of extract of Ginkgo biloba added to haloperidol in treatment-resistant patients with schizophrenia and its implications for patients with chronic, refractory schizophrenia. Expand
The effect of extract of ginkgo biloba addition to olanzapine on therapeutic effect and antioxidant enzyme levels in patients with schizophrenia
TLDR
The present study supported the findings of the previous study demonstrating that EGb might enhance the efficiency of antipsychotic in patients with schizophrenia, particularly on positive symptoms of the disorder. Expand
The effects of classic antipsychotic haloperidol plus the extract of ginkgo biloba on superoxide dismutase in patients with chronic refractory schizophrenia.
TLDR
EGb may enhance the efficacy of classic antipsychotic haloperidol on schizophrenia, especially on positive symptoms, and may work through an antioxidant efficacy that is involved in the therapeutic mechanism. Expand
Ginkgo biloba extract: mechanisms and clinical indications.
TLDR
Ginkgo shows promise in treating some of the neurologic sequelae associated with Alzheimer's disease, TBI, stroke, normal aging, edema, tinnitus, and macular degeneration and caution is advised when recommending ginkgo to patients taking anticoagulants. Expand
A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group.
TLDR
Ebb 761 was safe and appears capable of stabilizing and, in a substantial number of cases, improving the cognitive performance and the social functioning of demented patients for 6 months to 1 year. Expand
A Placebo-Controlled, Double-blind, Randomized Trial of an Extract of Ginkgo Biloba for Dementia
TLDR
EGb was safe and appears capable of stabilizing and, in a substantial number of cases, improving the cognitive performance and the social functioning of demented patients for 6 months to 1 year. Expand
A double-blind, placebo-controlled trial of extract of Ginkgo biloba added to haloperidol in treatment-resistant patients with schizophrenia.
TLDR
EGb treatment may enhance the effectiveness of antipsychotic drugs and reduce their extrapyramidal side effects in chronic, treatment-resistant inpatients with schizophrenia. Expand
...
1
2
3
4
5
...